Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 602-997-3 | CAS number: 124495-18-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 994
- Report date:
- 1994
- Reference Type:
- other: Supplemental report
- Title:
- Unnamed
- Year:
- 2 001
- Report date:
- 2001
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.5395 (In Vivo Mammalian Cytogenics Tests: Erythrocyte Micronucleus Assay)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- other: bone marrow micronucleus test
Test material
- Reference substance name:
- Reference substance 001
- Cas Number:
- 124495-18-7
- Test material form:
- solid: particulate/powder
Constituent 1
- Specific details on test material used for the study:
- - Substance ID: TSN 100097
- Name of substance: XDE-795
- Purity: 97.4%
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Inc., Portage, Michigan
- Assigned to test groups randomly: Yes
- Housing: Individually housed
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: At least 7 days
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- Corn oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: The test substance was mixed with corn oil for dosing. Cyclophosphamide (CP) was dissolved in distilled water. Freshly prepared solutions were used for dosing the animals. The concentrations of the test substance in the dosing solutions were verified by high pressure liquid chromatography (HPLC).
- Duration of treatment / exposure:
- 24, 48, or 72 h after treatment
- Frequency of treatment:
- single
Doses / concentrationsopen allclose all
- Dose / conc.:
- 1 250 mg/kg bw/day
- Dose / conc.:
- 2 500 mg/kg bw/day
- Dose / conc.:
- 5 000 mg/kg bw/day
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide
- Justification for choice of positive control: Cyclophosphamide was selected to induce an unequivocal positive response
- Route of administration: Oral
- Doses / concentrations: 120 mg/kg bw (10 mL/kg)
Examinations
- Tissues and cell types examined:
- Bone marrow cells
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: The highest dose level of 5000 mg/kg bw was based upon the results of a range-finding test and it is also the generally accepted limit dose for relatively non-toxic test substances.
BONE MARROW SAMPLING: At the end of the specified intervals following dosing, the animals were sacrificed by cervical dislocation. Bone marrow samples were obtained from both femurs in the following way. After separating the bone from the adjoining muscles, the distal end of the femur was severed to expose the marrow cavity. A 25-gauge needle was used to aspirate the bone marrow into a 3 ml disposable plastic syringe containing approximately 0.5 ml of fetal bovine serum. After aspiration, the contents of the syringe were transferred into a 1.5 ml centrifuge tube containing 0.5 ml of serum. The cells were resuspended in the serum by gentle aspiration using the syringe and needle. The tubes were centrifuged at 1000 rpm (approximately 80 g) for approximately 5 minutes in a table-top centrifuge. The supernatant was discarded leaving a small amount of serum covering the pellet. The cell pellet was resuspended using a disposable transfer pipette. Wedge smears were prepared on microscope slides using small portions of the cell suspension. The slides were allowed to air dry and stained with Wright-Giemsa using a Hematek automatic slide stainer.
SLIDE SCORING: The slides were coded and scored blindly. One thousand polychromatic erythrocytes were examined from each animal and the number of micronucleated polychromatic erythrocytes (MN-PCE) was recorded. Micronuclei were identified as darkly stained bodies with smooth contours and varying shapes such as round, almond, or ring. The ratio of PCE-NCE in the bone marrow was determined by examining 1000 erythrocytes. The ratio was expressed as PCEx100/PCE+NCE. - Statistics:
- The raw data on the counts of MN-PCE for each animal were first transformed by adding 1 to each count and then taking natural log of the adjusted number. The transformed MN-PCE data and the data on percent PCE were analyzed by a three-way analysis of variance (sex, dose, and time), assuming the three-way interaction to be zero. From this initial analysis, the two-way interactions were reviewed for significance. Depending upon this review, the data were analyzed by either one, two, or three-way analysis of variance looking only at main effects. Pairwise comparisons of treated vs. negative control groups were done, if necessary, by Dunnett's t-tests, one-sided (upper) for MN-PCE and two-sided for percent PCE. The alpha level at which all the tests were conducted was 0.01.
The final interpretation of biological significance of the responses was based on both statistical outcome and scientific judgment.
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 2500 and 5000 mg/kg bw
- Mortality: 10 of 10 animals treated with 5000 mg/kg bw of the test substance survived. At the 2500 mg/kg bw dose level, one female died on day two of observation. Necropsy of the dead animal indicated no evidence of gavage error. The cause of death was undetermined.
- Clinical signs of toxicity in test animals: All animals appeared normal immediately after dosing. At three hours post-dosing, all animals were exhibiting signs of lethargy. Six hours after dosing, one female and three males in the 2500 mg/kg bw group and two females and all males in the 5000 mg/kg bw group appeared to be lethargic. On day two of observation, one female in the 2500 mg/kg bw dose group was recorded as jumping violently and displaying erratic behavior. This animal died the same day. Two males in the 2500 mg/kg bw group remained lethargic on day 2 of observation. On day three of observations, two males were recorded as extremely lethargic and not eating as evidence of lack of fecal droppings under their cages. One of these males also had perineal staining.
RESULTS OF DEFINITIVE STUDY
- Clinical signs of toxicity: Lethargy was observed in most of the male mice treated with the test material two hours after dosing. At four hours post dosing, males in the 1250 mg/kg bw dose group appeared somewhat lethargic. Those in the 2500 mg/kg bw dose group were expressing varying degrees of lethargy and 7 of the 10 males in the 5000 mg/kg bw dose group appeared lethargic. At the 24-hour sacrifice, all males treated with the test materials had varying degrees of perianal staining. Lethargy was also observed in the 5000 mg/kg bw male group. The remaining males appeared to return to normal on day three of observation. At the 72 h sacrifice, a 1250mg/kg bw male group could not open its eyes due to ocular discharge.
- Induction of micronuclei: There were no significant differences in MN-PCE frequencies between the groups treated with the test substance and the negative controls. The positive control chemical, CP, induced a significant increase in the frequencies of micronucleated polychromatic erythrocytes. The percent PCE values observed in the test substance-treated animals were not significantly different from the negative control values at any dose level tested. However, the %PCE values in the test substance treated males tended to be lower than the negative controls especially in the groups harvested at 48 and 72 h after treatment. The biological significance of this trend, nevertheless, is uncertain. The positive control chemical (CP), on the other hand, had a significant effect on the ratio of PCE to NCE.
Applicant's summary and conclusion
- Conclusions:
- Negative mouse micronucleus test
- Executive summary:
The test substance was evaluated in the mouse bone marrow micronucleus test following OECD guideline 474 and US EPA 798.5395. The micronucleus test is capable of detecting agents causing chromosomal aberrations and spindle malfunction. The test substance was administered to CD-1 mice by single oral gavage at dose levels of 0 (negative control), 1250, 2500, and 5000 mg/kg body weight. The highest dose level of 5000 mg/kg bw was based. upon the results of a range-finding test and it is also the generally accepted limit dose for relatively non-toxic test substances. The concentrations of the test substance in the dosing solutions were verified by analytical methods. Groups of animals were sacrificed at 24, 48, or 72 h after treatment. Mice treated with 120 mg/kg bw cyclophosphamide and sacrificed at 24 h served as positive controls. There were five animals per sex per dose level per sacrifice time. One thousand polychromatic erythrocytes (PCE) were evaluated from each surviving animal and the frequencies of micronucleated polychromatic erythrocytes (MN-PCE) were recorded. There were no statistically significant increases in the frequencies of MN-PCE in groups treated with the test substance as compared to negative controls. The positive control mice showed significant increases in MN-PCE. Hence, under the experimental conditions used, the test substance was considered to be negative in the mouse bone marrow micronucleus test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.